Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: The Framingham offspring study

Atherosclerosis

Volumn 158, Issue 1, 2001, Pages 173-181

  Russo, Giuseppina T ^a   Meigs, James B ^b   Cupples, L Adrienne ^c   Demissie, Serkalem ^c   Otvos, James D ^d   Wilson, Peter W F ^e   Lahoz, Carlos ^a   Cucinotta, Domenico ^f   Couture, Patrick ^a   Mallory, Tonya ^g   Schaefer, Ernst J ^a   Ordovas, Jose M ^a  

^a TUFTS UNIVERSITY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^d NORTH CAROLINA STATE UNIVERSITY   (United States)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^f UNIVERSITY OF MESSINA   (Italy)

^g Wako Diagnostics   (United States)

Author keywords

apoC3; Insulin resistance; Lipoprotein particle size; Polymorphisms; Triglycerides

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN C3; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

3' UNTRANSLATED REGION; ADULT; ALLELE; ARTICLE; BIOCHEMISTRY; CARDIOVASCULAR RISK; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENETIC POLYMORPHISM; GENOTYPE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; INSULIN BLOOD LEVEL; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ONSET AGE; PRIORITY JOURNAL; PROGENY;

ALLELES; APOLIPOPROTEIN C-III; APOLIPOPROTEINS C; CHROMOSOMES, HUMAN, PAIR 11; CORONARY DISEASE; FEMALE; HUMANS; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 0034898391     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(01)00409-9     Document Type: Article

References (69)

1. Gene-diet interaction in determining plasma lipid response to dietary intervention
2. Apolipoprotein genetic variation and human disease
3. Familial hypercolesterolemia
4. Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome
5. Hypetriglyceridemia associated with deficiency of apolipoprotein C-II
6. Genetic dyslipoproteinemias: Role of lipoprotein lipase and apolipoprotein CII
7. Apolipoprotein AI deficiency: Biochemical and metabolic characteristics
8. Apolipoprotein E polymorphism and atherosclerosis
9. Risk of fatal coronary heart disease in familial hypercolesterolemia
10. Risk of ischaemic heart disease in familial hyperlipoproteinaemic states
11. Human apolipoprotein A-I-C-III gene complex is located on chromosome 11
12. A-1 Milano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family
13. Role of ApoCs in lipoprotein metabolism. Functional differences between ApoC1, ApoC2, and ApoC3
14. Inhibitory effect of C apolipoproetins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver
15. Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein CIII
16. Hypertriglyceridemia as a result of human ApoCIII gene expression in transgenic mice
17. Variation at the apo AI/CIII/AIV gene complex is associated with elevated plasma levels of ApoCIII
18. Apolipoprotein levels in non-insulin-dependent diabetes mellitus with clinical macroangiopathy
19. Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts; lipid and non-lipid factors
20. Apolipoprotein C-III gene variation and dyslipidaemia
21. Deoxyribonucleic acid polymorphism in the apolipoprotein A-1-C-III gene cluster. Association with hypertriglyceridemia
22. Strong association of a single nucleotide substitution in the 3′-untranslated region of the apolipoprotein-CIII gene with common hypertriglyceridemia in arabs
23. Haplotypes identificated by DNA polymorphisms at the apolipoprotein A-1 and C-III loci and hypertriglyceridemia. A study in a Japanese population
24. An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3′untranslated region polymorphisms
25. An apolipoprotein CIII marker associated with hypertriglyceridemia in Caucasians also confers increased risk in a west Japanese population
26. Blood pressure, coronary artery disease, and glycaemic control in type 2 diabetes mellitus: Relation to apolipoprotein-CIII gene polymorphism
27. Genetic polymorphism of apolipoprotein C-III and insulin survivors of myocardical infarction
28. DNA polymorphism in and around the Apo-A1-CIII genes and genetic hyperlipidemias
29. Restriction fragment lenght polymorphisms of the apolipoprotein A-I, C-III, A-IV gene locus. Relationship with lipids, apolipoproteins, and premature coronary artery disease
30. Hypertriglyceridemia and apolipoprotein CIII gene locus: Lack of association with the variant insulin response element in Italian school children
31. The Framingham offspring study. Design and preliminary data
32. An investigation of coronary heart disease in families. The Framingham offspring study
33. Epidemiological approach to heart disease: The Framingham study
34. The coronary prevention trial: Design and implementation
35. Multi-laboratory comparison of three heparin-Mn2+ precipitation procedures for estimating cholesterol in high-density lipoprotein
36. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
37. Metabolism of apolipoproetins A-I, A-II, A-IV
38. Enzyme-linked immunosorbent assay for human plasma apolipoprotein B
39. Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement
40. Labile glycosylated hemoglobin contributes to hemoglobin A1 as measured by liquid chromatography or electrophoresis
41. A simple salting out procedure for extracting DNA from human nucleated cells
42. Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism
43. Multipoint quantitative-trait linkage analysis in general pedigrees
44. Polymorphisms of the genes encoding apolipoproteins A-I, B,C-III, and E and LDL receptor, and cholesterol and LDL metabolism during increased cholesterol intake. Common alleles of the apoprotein E gene show the greatest regulatory impact
45. DNA polymorphisms of apolipoprotein A-I/ C-III and insulin genes in familial hypertriglyceridemia and coronary heart disease
46. A major locus influencing plasma high-density lipoprotein cholesterol levels in the San antonio family heart study. Segregation and linkage analyses
47. Gene and gene-product variation in the apoilpoprotein A-I/C-III/A-IV cluster in the Dogrib Indians of the northwest territories
48. Apolipoprotein A-I/C-III/A-IV gene cluster in familial combined hyperlipidemia: Effects on LDL-cholesterol and apolipoproteins B and CIII
49. Intestinal expression of the human apoA-I gene in transgenic mice is controlled by a DNA region 3′ to the gene in the promoter of the adjacent convergently apoC-III gene
50. Genes, variation of cholesterol and fat intake and serum lipids
51. Influence of the SstI polymorphism at the apolipoprotein C-III gene locus on the plasma low-density-lipoprotein-cholesterol response to dietary monosatureated fat
52. Patterns of association between genetic variability in apolipoprotein (Apo) B, Apo AI-CIII- AIV, and cholesterol ester transfer protein gene regions and quantitative variation in lipid and lipoprotein traits: Influence of gender and exogenous hormones
53. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham offspring study
54. Gene-gene interaction between the low density lipoprotein receptor and apolipoprotein E loci affects lipid levels
55. A gene-gender interaction affecting plasma lipoproteins in a genetic isolate
56. Variation at the lipoprotein lipase and apolipoprotein AI-CIII gene loci are associated with fasting lipid and lipoprotein traits in a population sample from Iceland: Interaction between genotype, gender, and smoking status
57. The lipoprotein lipase HindIII polymorphism: Association with total cholesterol, but not with hdl and triglycerides in 342 females
58. Effects of gender and menopausal status on association of apolipoprotein E phenotype with plasma lipoprotein levels. Results from the Framingham offspring study
59. Multilocus genetic determinants of LDL particle size in coronary artery diseas families
60. DNA polymorphism adjacent to human apoprotein A-I gene. Relation to hypertrigliceridemia
61. Common genomic variation in the APOC3 promoter associated with variation in plasma lipoproteins
62. Polymorphic markers in apolipoprotein C-III gene flanking regions and hypertriglyceridemia
63. Common genetic variation in the promoter of the human apoCIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia
64. Association of plasma lipids and apolipoproteins with the insulin response element in the APOC-III promoter region in familial combined hyperlipidemia
65. Exploration of simple insulin sensitivity measures derived from frequently sampled intravenous glucose tolerance (FSIGT) tests. The insulin resistance atherosclerosis study
66. Genetic analysis of the IRS. Pleiotropic effects of genes influencing insulin levels on lipoprotein and obesity measures
67. The SstI polymorphism of the apolipoprotein C-III gene determines the insulin response to an oral-glucose-tolerance test after consumption of a diet rich in satured fats
68. Nutrient intake comparison between Framingham and rural and urban Puriscal, Costa Rica: Associations with lipoproteins, apolipoproteins, and low density lipoprotein particle size
69. Population nutrient intake approaches dietary recommendations: 1991-1995 Framingham nutrition studies